Antiviral effect of hyperthermic treatment in rhinovirus infection.
Human rhinoviruses (HRV) are recognized as the major etiologic agents for the common cold. Starting from the observation that local hyperthermic treatment is beneficial in patients with natural and experimental common colds, we have studied the effect of brief hyperthermic treatment (HT) on HRV replication in HeLa cells. We report that a 20-min HT at 45 degrees C is effective in suppressing HRV multiplication by more than 90% when applied at specific stages of the virus replication cycle. Synthesis of virus proteins is not affected by HT, indicating that the target for treatment is a posttranslational event. The antiviral effect is a transient cell-mediated event and is associated with the synthesis of the 70-kDa heat shock protein hsp70. Unlike poliovirus, rhinovirus infection does not inhibit the expression of hsp70 induced by heat. The possibility that hsp70 could play a role in the control of rhinovirus replication is suggested by the fact that a different class of HSP inducers, the cyclopentenone prostaglandins PGA1 and delta 12-PGJ2, were also effective in inhibiting HRV replication in HeLa cells. Inhibition of hsp70 expression by actinomycin D prevented the antiviral activity of prostaglandins in HRV-infected cells. These results indicate that the beneficial effect of respiratory hyperthermia may be mediated by the induction of a cytoprotective heat shock response in rhinovirus-infected cells.
Conti
C
C
Institute of Microbiology, School of Medicine, University La Sapienza, Rome, Italy.
De Marco
A
A
Mastromarino
P
P
Tomao
P
P
Santoro
M G
MG
D000998:Antiviral Agents / Q000494:pharmacology; D003139:Common Cold / Q000628:therapy*; D006367:HeLa Cells / Q000187:drug effects / Q000821:virology; D006801:Humans; D006979:Hyperthermia, Induced; D015230:Prostaglandin D2 / Q000494:pharmacology / Q000031:analogs & derivatives; D011454:Prostaglandins A / Q000494:pharmacology; D012229:Rhinovirus / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D011454:Prostaglandins A; D014764:Viral Proteins; C040810:9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2; D015230:Prostaglandin D2; C100573:prostaglandin A1